SCHEMBL29101237

SCHEMBL29101237

COCOc1cc(-c2cnn(C3CCCO3)c2)ccc1B1OC(C)(C)C(C)(C)O1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 4/20 0.37
FGFR2 P21802 3/20 0.37
FGFR4 P22455 3/20 0.37
FGFR3 P22607 3/20 0.37
KDR P35968 3/20 0.37
FLT3 P36888 2/20 0.37
IRAK1 P51617 1/20 0.33
KDM5B Q9UGL1 1/20 0.33
WNT1 P04628 1/20 0.32
GSK3B P49841 1/20 0.32
DYRK1A Q13627 1/20 0.32
TTK P33981 1/20 0.32
SYK P43405 1/20 0.31
AURKB Q96GD4 1/20 0.31
MCL1 Q07820 1/20 0.31
USP2 O75604 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HTT P42858 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
RIPK1 Q13546 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18956280 0.97 FGFR1 (0.39) FGFR1FGFR2FGFR4FGFR3KDR
SCHEMBL18956281 0.87 FGFR1 (0.40) FGFR1FGFR2FGFR4FGFR3KDR
SCHEMBL30229086 0.83 FGFR1 (0.38) FGFR1FGFR2FGFR4FGFR3KDR
SCHEMBL23290783 0.82 IDH1 (0.41) FGFR1FGFR2FGFR4FGFR3KDR
SCHEMBL25092518 0.82 TTK (0.39) IRAK1WNT1GSK3BDYRK1ATTK
SCHEMBL25680952 0.80 KDM5B (0.37) FGFR1FGFR2FGFR4FGFR3KDR
SCHEMBL21410506 0.79 FGFR1 (0.41) FGFR1FGFR2FGFR4FGFR3KDR
SCHEMBL29447066 0.79 FGFR1 (0.41) FGFR1FGFR2FGFR4FGFR3KDR
SCHEMBL23291098 0.79 FGFR1 (0.41) FGFR1FGFR2FGFR4FGFR3KDR
SCHEMBL25065220 0.78 KDM5B (0.43) FGFR1FGFR2FGFR4FGFR3KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116940578-A 5- [5- (piperidin-4-yl) thieno [3,2-C ] pyrazol-2-yl ] indazole derivatives and related compounds as modulators for splicing nucleic acids and for the treatment of proliferative diseases 雷密克斯医疗公司 2023-10-24 CN disclosed